☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Approval
Profound Medical’s Contouring Assistant AI Module Gains the US FDA’s Approval for Creating Automated TULSA Treatment Plan
May 15, 2024
Roche Receives the US FDA’s Approval for HPV Self-Collection Solutions for Cervical Cancer
May 15, 2024
Zai Lab’s Augtyro Receives the NMPA’s Approval to Treat Non-Small-Cell Lung Cancer (NSCLC)
May 13, 2024
Biotheryx Receives the US FDA’s IND Approval of BTX-9341 for Treating Breast Cancer
May 8, 2024
The US FDA Approves High Concentration of Boehringer Ingelheim's Cyltezo (Biosimilar, Humira)
May 2, 2024
X4 Pharmaceuticals’ Xolremdi Receives the US FDA’s Approval for the Treatment of WHIM Syndrome
April 30, 2024
Load more...
Back to Home